Leyla R. Brucar

Leyla R. Brucar

Auto-generated profile, based on publicly available information

Leyla R. Brucar

Department of Psychiatry & Behavioral Sciences, University of Minnesota, Minneapolis, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2023 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
GDGunner Drossel
Gunner Drossel
LBLeyla R. Brucar
Leyla R. Brucar
EREric Rawls
Eric Rawls
THTimothy J. Hendrickson
Timothy J. Hendrickson
AZAnna Zilverstand
Anna Zilverstand
Rates of return to use in addiction treatment remain high. We argue that the development of improved treatment options will require advanced understanding of individual heterogeneity in Substance Use Disorders (SUDs). We hypothesized that considerable individual differences exist in the three functional domains underlying addiction—approach-related behavior, executive function, and negative emotionality. We included N = 593 participants from the enhanced Nathan Kline Institute-Rockland Sample community sample (ages 18–59, 67% female) that included N = 420 Controls and N = 173 with past SUDs [54% female; N = 75 Alcohol Use Disorder (AUD) only, N = 30 Cannabis Use Disorder (CUD) only, and N = 68 Multiple SUDs]. To test our a priori hypothesis that distinct neuro-behavioral subtypes exist within individuals with past SUDs, we conducted a latent profile analysis with all available phenotypic data as input (74 subscales from 18 measures), and then characterized resting-state brain function for each discovered subtype. Three subtypes with distinct neurobehavioral profiles were recovered (p < 0.05, Cohen’s D: 0.4–2.8): a “Reward type” with higher approach-related behavior (N = 69); a “Cognitive type” with lower executive function (N = 70); and a “Relief type” with high negative emotionality (N = 34). For those in the Reward type, substance use mapped onto resting-state connectivity in the Value/Reward, Ventral-Frontoparietal and Salience networks; for the Cognitive type in the Auditory, Parietal Association, Frontoparietal and Salience networks; and for the Relief type in the Parietal Association, Higher Visual and Salience networks (pFDR < 0.05). Subtypes were equally distributed amongst individuals with different primary SUDs (χ2 = 4.71, p = 0.32) and gender (χ2 = 3.44, p = 0.18). Results support functionally derived subtypes, demonstrating considerable individual heterogeneity in the multi-dimensional impairments in addiction. This confirms the need for mechanism-based subtyping to inform the development of personalized addiction medicine approaches.


6 June 2025 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
LBLeyla R. Brucar
Leyla R. Brucar
EREric Rawls
Eric Rawls
AHAnn F. Haynos
Ann F. Haynos
CPCarol B. Peterson
Carol B. Peterson
AZAnna Zilverstand
Anna Zilverstand
Binge eating (BE), a transdiagnostic feature that occurs across eating disorders and in the general population, carries significant health risks even in the absence of a full-syndrome diagnosis. The limited efficacy of current treatments for binge-type eating disorders highlights the need to better understand the mechanistic heterogeneity underlying BE to optimize treatment allocation, advance personalized medicine, and ultimately improve outcomes. We hypothesized considerable heterogeneity within three neurofunctional domains prevalent across compulsive behaviors and implicated in BE: approach-related behavior, executive function, and negative emotionality. We analyzed data from 612 participants (ages 18–59, 66% female) from the enhanced Nathan Kline Institute-Rockland Sample, including 461 controls and 151 individuals with BE behaviors. Using data-driven statistical modeling of comprehensive, multimodal measures across the three hypothesized domains, we identified subtypes of BE. Subtypes were validated using assessments of eating pathology, substance use, clinical diagnostics, and resting-state functional magnetic resonance imaging. Three distinct and stable subtypes emerged: a ‘Negative Emotionality’ subtype characterized by greater negative affect, emotion dysregulation and psychiatric comorbidity, an ‘Approach’ subtype with higher approach-related and impulsive behaviors, and a ‘Restrained’ subtype that was overcontrolled and harm avoidant. The Approach and Restrained subtypes further demonstrated unique neurobiological profiles, as determined by graph theory analysis of resting-state functional connectivity. All subtypes showed similar proportions of BE episodes meeting clinical-level threshold (≥4 objective binge episodes/month), and no differences in BMI, indicating functionally distinct expressions of BE, beyond clinical severity and diagnostic classification. This study is the first to explore the mechanistic heterogeneity of BE through a comprehensive multi-modal assessment across three neurofunctional domains in a single sample. Findings highlight the need for updated models of BE etiology that integrate approach/reward-related behaviors, impulsivity and overcontrolled behaviors, and negative emotionality, and suggest the potential of these functionally-derived subtypes to inform the development of personalized, targeted interventions.

6 May 2025 in JAACAP Open
Verified
Journal Article
Open access
GNGregory R. Niklason
Gregory R. Niklason
AMAndrea M. Maxwell
Andrea M. Maxwell
LBLeyla R. Brucar
Leyla R. Brucar
COCaroline Ostrand
Caroline Ostrand
EKErich Kummerfeld
Erich Kummerfeld
AZAnna Zilverstand
Anna Zilverstand
Extant research has focused on the risk factors for alcohol use in adolescence, but little work has examined these in childhood. Early alcohol sipping, defined here as sipping alcohol by ages 9 to 10, may be a unique and informative developmental precursor to future problematic alcohol use. This study employed machine learning to rank risk factors linked to early alcohol sipping by importance. Data from a subset of the Adolescent Brain Cognitive Development℠ (ABCD) Study sample were used (n = 10,707 children ages 9-10 years old; 48.1% girls). Two state-of-the-art machine learning techniques, eXtreme Gradient Boosting (XGBoost) and Shapley Additive exPlanations (SHAP), were combined to rank 341 environmental, 359 health, and 127 psychological factors and 1,332 indicators of brain function by their importance in classifying children with early alcohol sipping. The environmental classification model yielded the highest classification performance (area under the curve = 0.76; 95% CI, 0.749-0.774). Factors related to family norms, socioeconomic status, parental stress, and maternal alcohol use were most important for identifying a child with early alcohol sipping. The health classification model had the second highest performance (area under the curve = 0.68; 95% CI, 0.662-0.690), with sleep patterns, early puberty onset, and mental health symptoms the most important for classifying early sipping. The psychological model yielded the third highest classification performance (area under the curve = 0.65; 95% CI, 0.638-0.667) and linked negative affect, sensation seeking, impulsivity, and impaired reward processing to sipping. Models that included brain indices performed only marginally better than chance. Taken together, these results suggest that the factors underlying early alcohol sipping are similar to the factors underlying problematic alcohol use later in life and that interventions targeting these early in life may be effective at preventing future alcohol use. We worked to ensure sex and gender balance in the recruitment of human participants. We worked to ensure race, ethnic, and/or other types of diversity in the recruitment of human participants. We worked to ensure that the study questionnaires were prepared in an inclusive way. We worked to ensure sex balance in the selection of non-human subjects. One or more of the authors of this paper self-identifies as a member of one or more historically underrepresented racial and/or ethnic groups in science. One or more of the authors of this paper self-identifies as a member of one or more historically underrepresented sexual and/or gender groups in science. One or more of the authors of this paper self-identifies as living with a disability. We actively worked to promote sex and gender balance in our author group. One or more of the authors of this paper received support from a program designed to increase minority representation in science. We actively worked to promote inclusion of historically underrepresented racial and/or ethnic groups in science in our author group. While citing references scientifically relevant for this work, we also actively worked to promote sex and gender balance in our reference list. While citing references scientifically relevant for this work, we also actively worked to promote inclusion of historically underrepresented racial and/or ethnic groups in science in our reference list. The author list of this paper includes contributors from the location and/or community where the research was conducted who participated in the data collection, design, analysis, and/or interpretation of the work.

20 November 2025 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
LBLeyla R. Brucar
Leyla R. Brucar
GDGunner Drossel
Gunner Drossel
EGEduardo A. Garza-Villarreal
Eduardo A. Garza-Villarreal
AZAnna Zilverstand
Anna Zilverstand
Cocaine Use Disorder (CUD) afflicts over 1.4 million individuals in the United States alone. However, current treatments are largely ineffective, with up to 85% returning to use long-term. We posit that addressing functional heterogeneity underlying CUD is crucial for improving treatment success. Based on prior work, we hypothesized heterogeneity in function across three domains: approach-related behavior, executive function, and negative emotionality. We analyzed data from 109 participants (ages 22-39, 15% female, N = 61 CUD) from the SUDMEX CONN dataset. To test if distinct ‘mechanism-based’ subtypes exist within CUD, we conducted a Latent Profile Analysis using phenotypic data as input. The discovered subtypes were characterized regarding their use characteristics, psychiatric diagnostics, and resting-state functional connectivity (rsFC). Three distinct subtypes emerged (p < 0.05, partial eta squared: 0.19–0.51): a ‘Relief Type’ with high negative emotionality (N = 22); a ‘Cognitive Type’ with lower executive function (N = 15); and an ‘Undefined Type’ with no apparent impairments (N = 24). Consistent with this profile, the Relief Type had more comorbid psychiatric diagnoses. Furthermore, each subtype demonstrated a unique neurobiological profile underlying their current cocaine use (pFDR < 0.05): the Relief Type showed aberrant rsFC in Limbic/Memory and Salience networks; the Cognitive Type in Frontoparietal, higher visual, Motor Planning, Salience, and Parietal Association networks; and the ‘Undefined Type’, in Motor Planning, Ventral Frontoparietal, Salience, and Default-Mode networks. Importantly, despite these distinct profiles, CUD severity was equivalent between all three subtypes. Results highlight significant heterogeneity in the mechanisms underlying CUD, emphasizing the importance of mechanism-based subtyping to inform the development of targeted treatments.

11 July 2026 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
LBLeyla R. Brucar
Leyla R. Brucar
EREric Rawls
Eric Rawls
AZAnna Zilverstand
Anna Zilverstand
Alcohol Use Disorder (AUD) is associated with vast clinical, behavioral, and neurobiological heterogeneity that hinder both the efficacy of current interventions and future treatment development. While recent efforts have focused on stratifying psychiatric disorders based on underlying neurobiological markers, such approaches remain largely unexplored in AUD. To address this, we empirically-derived neurobiological subtypes of AUD and evaluated their reproducibility and clinical relevance. Participants with complete resting-state functional MRI (rs-fMRI), phenotypic and clinical data from the Human Connectome Project were included (N = 668; 58% Female; 22% AUD [mild AUD: n = 109; moderate-severe AUD: n = 38], 40% Female within AUD). Neurobiological subtypes of AUD were identified using a semi-supervised clustering approach based on graph theory metrics derived from whole-brain rs-fMRI. Subtypes were extensively validated for reproducibility using resampling, permutation testing, and temporal stability, and for clinical relevance using comprehensive assessments of multi-modal behaviors and clinical characteristics. Two robust and distinct neurobiological subtypes of AUD with unique clinical profiles emerged. Subtype 1 showed greater sensory-motor integration, but lower frontoparietal/salience integration, with elevated externalizing behaviors. Subtype 2 demonstrated the opposite pattern: greater integration in frontoparietal, salience, and default-mode networks, and lower sensory-motor integration, characterized primarily by internalizing behaviors. Subtypes did not differ by AUD symptoms or use characteristics. Importantly, the subtype structure and phenotypic profiles remained robust when including AUD individuals with comorbid cannabis dependence, supporting generalizability and translational relevance to clinically comorbid populations. In summary, we identified neurobiological subtypes of AUD with distinct phenotypic and clinical profiles, capturing greater nuance than previous phenotypically-derived subgroups, while remaining interpretable and clinically meaningful. These findings provide a robust framework for understanding AUD’s underlying mechanisms and underscore their potential for a neurobiologically informed approach to nosology, treatment allocation, and personalized interventions in AUD.